| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | thiamine pyrophosphate binding | 9.42e-06 | 8 | 112 | 3 | GO:0030976 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.28e-04 | 138 | 112 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 1.83e-04 | 20 | 112 | 3 | GO:0015174 | |
| GeneOntologyMolecularFunction | oxoglutarate dehydrogenase (succinyl-transferring) activity | 1.86e-04 | 4 | 112 | 2 | GO:0004591 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.67e-04 | 96 | 112 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | PR-DUB complex | 1.70e-04 | 4 | 112 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | myosin filament | 3.16e-04 | 25 | 112 | 3 | GO:0032982 | |
| Domain | Transketolase-like_Pyr-bd | 1.15e-05 | 8 | 112 | 3 | IPR005475 | |
| Domain | Transket_pyr | 1.15e-05 | 8 | 112 | 3 | SM00861 | |
| Domain | Transket_pyr | 1.15e-05 | 8 | 112 | 3 | PF02779 | |
| Domain | 2-oxogl_dehyd_N | 3.56e-05 | 2 | 112 | 2 | IPR032106 | |
| Domain | 2-oxogl_dehyd_N | 3.56e-05 | 2 | 112 | 2 | PF16078 | |
| Domain | THDP-binding | 5.75e-05 | 13 | 112 | 3 | IPR029061 | |
| Domain | - | 5.75e-05 | 13 | 112 | 3 | 3.40.50.970 | |
| Domain | HARE-HTH | 1.07e-04 | 3 | 112 | 2 | PF05066 | |
| Domain | ASXH | 1.07e-04 | 3 | 112 | 2 | PF13919 | |
| Domain | PHD_3 | 1.07e-04 | 3 | 112 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 1.07e-04 | 3 | 112 | 2 | IPR026905 | |
| Domain | 2oxoglutarate_DH_E1 | 1.07e-04 | 3 | 112 | 2 | IPR011603 | |
| Domain | ASXH | 1.07e-04 | 3 | 112 | 2 | IPR028020 | |
| Domain | KGD_C | 1.07e-04 | 3 | 112 | 2 | IPR031717 | |
| Domain | ASX/ASX-like | 1.07e-04 | 3 | 112 | 2 | IPR024811 | |
| Domain | OxoGdeHyase_C | 1.07e-04 | 3 | 112 | 2 | PF16870 | |
| Domain | HB1/Asxl_HTH | 1.07e-04 | 3 | 112 | 2 | IPR007759 | |
| Domain | FN3 | 1.98e-04 | 199 | 112 | 7 | PS50853 | |
| Domain | FN3_dom | 2.67e-04 | 209 | 112 | 7 | IPR003961 | |
| Domain | ZF_PHD_2 | 2.67e-04 | 95 | 112 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 2.81e-04 | 96 | 112 | 5 | PS01359 | |
| Domain | fn3 | 4.35e-04 | 162 | 112 | 6 | PF00041 | |
| Domain | E1_dh | 5.26e-04 | 6 | 112 | 2 | PF00676 | |
| Domain | DH_E1 | 5.26e-04 | 6 | 112 | 2 | IPR001017 | |
| Domain | S04_transporter_CS | 7.34e-04 | 7 | 112 | 2 | IPR018045 | |
| Domain | FN3 | 8.74e-04 | 185 | 112 | 6 | SM00060 | |
| Domain | SLC26A | 1.55e-03 | 10 | 112 | 2 | PS01130 | |
| Domain | STAS | 1.89e-03 | 11 | 112 | 2 | PS50801 | |
| Domain | ZF_CXXC | 1.89e-03 | 11 | 112 | 2 | PS51058 | |
| Domain | IL6Ra-bind | 1.89e-03 | 11 | 112 | 2 | PF09240 | |
| Domain | BAH | 1.89e-03 | 11 | 112 | 2 | PS51038 | |
| Domain | STAS | 1.89e-03 | 11 | 112 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 1.89e-03 | 11 | 112 | 2 | IPR001902 | |
| Domain | BAH_dom | 1.89e-03 | 11 | 112 | 2 | IPR001025 | |
| Domain | BAH | 1.89e-03 | 11 | 112 | 2 | SM00439 | |
| Domain | STAS_dom | 1.89e-03 | 11 | 112 | 2 | IPR002645 | |
| Domain | Znf_CXXC | 1.89e-03 | 11 | 112 | 2 | IPR002857 | |
| Domain | SLC26A/SulP_dom | 1.89e-03 | 11 | 112 | 2 | IPR011547 | |
| Domain | BAH | 1.89e-03 | 11 | 112 | 2 | PF01426 | |
| Domain | zf-CXXC | 1.89e-03 | 11 | 112 | 2 | PF02008 | |
| Domain | - | 1.89e-03 | 11 | 112 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 1.89e-03 | 11 | 112 | 2 | PF00916 | |
| Domain | TypeI_recpt_CBD | 1.89e-03 | 11 | 112 | 2 | IPR015321 | |
| Domain | Znf_PHD | 2.19e-03 | 91 | 112 | 4 | IPR001965 | |
| Domain | PX | 2.32e-03 | 44 | 112 | 3 | SM00312 | |
| Domain | AA_permease_2 | 2.66e-03 | 13 | 112 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 2.66e-03 | 13 | 112 | 2 | IPR002293 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 3.73e-05 | 12 | 80 | 3 | M27738 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ELOA DHX37 SYNPO SRCAP CHAMP1 GATAD2B PBRM1 NOP14 BAZ1A ZBTB21 KDM2A DNMT1 | 7.99e-07 | 608 | 114 | 12 | 36089195 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TTLL3 CARMIL1 RNF213 SYNPO IDE OGDH NRP1 CSDE1 SNX30 SH3PXD2A CDK5RAP1 IGSF9 KDM2A GREB1 HPS5 CRAMP1 TRAPPC9 | 7.26e-06 | 1489 | 114 | 17 | 28611215 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | EMC3 PLGRKT MRPL30 RNF213 IDE LBR OGDH POLR3A STAU1 SCYL2 PIKFYVE NOP14 MRPL16 PI4KA CDK5RAP1 OGDHL TRIM13 | 7.71e-06 | 1496 | 114 | 17 | 32877691 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ELOA DHX37 MYO18A OGDH STAU1 CSDE1 PBRM1 NOP14 BAZ1A OGDHL UTP20 DNMT1 | 7.75e-06 | 759 | 114 | 12 | 35915203 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1B DHX37 LBR SRCAP POLR3A STAU1 CSDE1 NOP14 BAZ1A TKT PI4KA UTP20 KDM2A RIC8A DDX60L DNMT1 | 8.98e-06 | 1353 | 114 | 16 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ELOA RPS6KA5 CARMIL1 MYO18A CHAMP1 GATAD2B PPL MED24 TKT ZBTB21 UTP20 DNMT1 | 9.43e-06 | 774 | 114 | 12 | 15302935 |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 12628722 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 36068610 | ||
| Pubmed | ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia. | 1.07e-05 | 2 | 114 | 2 | 28516957 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 22573740 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23597150 | ||
| Pubmed | PI4KA and PIKfyve: Essential phosphoinositide signaling enzymes involved in myriad human diseases. | 1.07e-05 | 2 | 114 | 2 | 37453227 | |
| Pubmed | A network of chaperones prevents and detects failures in membrane protein lipid bilayer integration. | 1.52e-05 | 15 | 114 | 3 | 30737405 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MPP3 ANKS6 SETD1B ZDHHC5 SRCAP LYST PIKFYVE UNC119 SNX30 PI4KA OGDHL RIC8A CRAMP1 TRAPPC9 | 1.61e-05 | 1105 | 114 | 14 | 35748872 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.76e-05 | 341 | 114 | 8 | 32971831 | |
| Pubmed | ASXL1 DHX37 MYO18A KLF15 LBR SRCAP GATAD2B STAU1 MED24 PBRM1 NOP14 MRPL16 DPF3 ZBTB21 ASXL2 TRAPPC9 | 1.76e-05 | 1429 | 114 | 16 | 35140242 | |
| Pubmed | ELOA MYO18A SYNPO SRCAP OGDH LYST PRX PPL NOP14 KIAA0825 BAZ1A SH3PXD2A TKT ZBTB21 OGDHL MYBPC1 | 1.96e-05 | 1442 | 114 | 16 | 35575683 | |
| Pubmed | ELOA RNF213 CHAMP1 GATAD2B POLR3A CSDE1 MED24 PBRM1 BAZ1A TKT ZBTB21 KDM2A DNMT1 | 2.92e-05 | 1014 | 114 | 13 | 32416067 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 21047783 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 16412590 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 25835095 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 28063196 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 29284740 | ||
| Pubmed | Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase. | 3.19e-05 | 3 | 114 | 2 | 33731362 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 33751773 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 28941661 | ||
| Pubmed | 3.28e-05 | 55 | 114 | 4 | 27114453 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 3.75e-05 | 20 | 114 | 3 | 29785026 | |
| Pubmed | 5.62e-05 | 63 | 114 | 4 | 25680957 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 34170818 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 12935900 | ||
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 6.36e-05 | 4 | 114 | 2 | 34536441 | |
| Pubmed | 6.42e-05 | 529 | 114 | 9 | 14621295 | ||
| Pubmed | SLC26A3 TTLL3 TMPRSS4 SYNPO SLC7A6 SLC7A9 CSDE1 FSD1L BMX ANKEF1 ZBTB21 OGDHL HYDIN MYBPC1 | 8.79e-05 | 1293 | 114 | 14 | 15342556 | |
| Pubmed | Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles. | 1.06e-04 | 5 | 114 | 2 | 10024132 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 9440711 | ||
| Pubmed | Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. | 1.06e-04 | 5 | 114 | 2 | 19861489 | |
| Pubmed | Analysis of atherosclerosis susceptibility in mice with genetic defects in platelet function. | 1.06e-04 | 5 | 114 | 2 | 2369371 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.17e-04 | 332 | 114 | 7 | 32786267 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CARMIL1 LBR LYST UNC119 BMX SH3PXD2A PI4KA ZBTB21 SSH2 TRAPPC9 DNMT1 | 1.28e-04 | 861 | 114 | 11 | 36931259 |
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 11087667 | ||
| Pubmed | Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9. | 1.58e-04 | 6 | 114 | 2 | 11834742 | |
| Pubmed | 1.74e-04 | 157 | 114 | 5 | 30186101 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.78e-04 | 475 | 114 | 8 | 31040226 | |
| Pubmed | 1.91e-04 | 34 | 114 | 3 | 24026423 | ||
| Pubmed | 1.99e-04 | 483 | 114 | 8 | 36912080 | ||
| Pubmed | Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. | 2.21e-04 | 7 | 114 | 2 | 26816381 | |
| Pubmed | 2.28e-04 | 493 | 114 | 8 | 15368895 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOA CARMIL1 SRCAP CHAMP1 STAU1 SCYL2 CSDE1 BAZ1A TKT ZBTB21 DNMT1 | 2.57e-04 | 934 | 114 | 11 | 33916271 |
| Pubmed | 2.65e-04 | 504 | 114 | 8 | 34432599 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 18680430 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 29395339 | ||
| Pubmed | Predictive value of 8 genetic loci for serum uric acid concentration. | 2.94e-04 | 8 | 114 | 2 | 20162742 | |
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 20162743 | ||
| Pubmed | ZDHHC5 KLF15 SRCAP GATAD2B ZNF710 PBRM1 BAZ1A DPF3 ZBTB21 DNMT1 | 3.36e-04 | 808 | 114 | 10 | 20412781 | |
| Pubmed | 3.63e-04 | 102 | 114 | 4 | 10231032 | ||
| Pubmed | Gene duplication and neofunctionalization: POLR3G and POLR3GL. | 3.78e-04 | 9 | 114 | 2 | 24107381 | |
| Pubmed | 3.78e-04 | 9 | 114 | 2 | 26416890 | ||
| Pubmed | 3.78e-04 | 9 | 114 | 2 | 15901826 | ||
| Pubmed | Physiological roles and regulation of mammalian sulfate transporters. | 3.78e-04 | 9 | 114 | 2 | 11581495 | |
| Pubmed | Additional sex combs-like family genes are required for normal cardiovascular development. | 3.78e-04 | 9 | 114 | 2 | 24860998 | |
| Pubmed | ELOA IL13RA1 SETD1B MED24 PTCHD1 PACRGL PBRM1 TKT CDK5RAP1 KDM2A RIC8A SSH2 CRAMP1 | 4.17e-04 | 1327 | 114 | 13 | 32694731 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ASXL1 TRAF3IP1 CARMIL1 XDH IDE CHAMP1 PPL CSDE1 PBRM1 MRPL16 TKT ASXL2 | 4.18e-04 | 1155 | 114 | 12 | 20360068 |
| Pubmed | 4.19e-04 | 190 | 114 | 5 | 24816252 | ||
| Pubmed | 4.36e-04 | 107 | 114 | 4 | 11347906 | ||
| Pubmed | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | 4.71e-04 | 10 | 114 | 2 | 32669118 | |
| Pubmed | N-glycosylation and topology of the human SLC26 family of anion transport membrane proteins. | 4.71e-04 | 10 | 114 | 2 | 24647542 | |
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 9328433 | ||
| Pubmed | The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. | 4.71e-04 | 10 | 114 | 2 | 19815555 | |
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 19503597 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXR1 ASXL1 GATAD2B NOP14 BAZ1A PI4KA ZBTB21 UTP20 KDM2A ASXL2 | 5.31e-04 | 857 | 114 | 10 | 25609649 |
| Pubmed | A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells. | 5.75e-04 | 11 | 114 | 2 | 14625392 | |
| Pubmed | 5.75e-04 | 11 | 114 | 2 | 19890391 | ||
| Pubmed | 5.91e-04 | 116 | 114 | 4 | 21282530 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 6.18e-04 | 719 | 114 | 9 | 35337019 | |
| Pubmed | Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. | 6.88e-04 | 12 | 114 | 2 | 25438054 | |
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 6.88e-04 | 12 | 114 | 2 | 8618961 | |
| Pubmed | 7.53e-04 | 54 | 114 | 3 | 26288249 | ||
| Pubmed | 7.55e-04 | 591 | 114 | 8 | 15231748 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 7.65e-04 | 454 | 114 | 7 | 33226137 | |
| Pubmed | 7.76e-04 | 329 | 114 | 6 | 17474147 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 7.88e-04 | 330 | 114 | 6 | 33301849 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | ASXL1 SLC25A21 ANKS6 TTLL3 DCDC2C CARMIL1 IDE OGDH SH3PXD2A HECW2 TRAPPC9 RAPGEFL1 | 7.91e-04 | 1242 | 114 | 12 | 30973865 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX37 IDE LBR OGDH POLR3A STAU1 PBRM1 BAZ1A TKT PI4KA UTP20 DNMT1 MYBPC1 | 8.10e-04 | 1425 | 114 | 13 | 30948266 |
| Pubmed | Bmx is a downstream Rap1 effector in VEGF-induced endothelial cell activation. | 8.11e-04 | 13 | 114 | 2 | 15207703 | |
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 8.11e-04 | 13 | 114 | 2 | 22878500 | |
| Pubmed | TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. | 8.11e-04 | 13 | 114 | 2 | 16052631 | |
| Pubmed | 8.13e-04 | 332 | 114 | 6 | 25693804 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | IL31RA RPS6KA5 MRPL30 LYST GATAD2B PRX UNC119 SH3PXD2A DDX60L CPLANE1 | 8.41e-04 | 910 | 114 | 10 | 36736316 |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 8.82e-04 | 57 | 114 | 3 | 21886157 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.05e-03 | 349 | 114 | 6 | 25665578 | |
| Pubmed | Nucleosome-interacting proteins regulated by DNA and histone methylation. | 1.09e-03 | 15 | 114 | 2 | 21029866 | |
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 21045126 | ||
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 23785148 | ||
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 17640523 | ||
| Pubmed | Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1. | 1.09e-03 | 15 | 114 | 2 | 27030811 | |
| Pubmed | EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos. | 1.09e-03 | 15 | 114 | 2 | 26576615 | |
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 6696991 | ||
| Pubmed | 1.23e-03 | 360 | 114 | 6 | 33111431 | ||
| Pubmed | 1.24e-03 | 16 | 114 | 2 | 23047923 | ||
| Interaction | ZNF330 interactions | ELOA DHX37 KLF15 STAU1 PBRM1 NOP14 BAZ1A TKT ZBTB21 UTP20 KDM2A DNMT1 | 7.82e-06 | 446 | 113 | 12 | int:ZNF330 |
| GeneFamily | Fibronectin type III domain containing | 4.22e-05 | 160 | 72 | 6 | 555 | |
| GeneFamily | Solute carriers | SLC25A21 SLC26A3 SLC35D2 SLC26A4 FLVCR2 SLC7A6 SLC7A9 SLC15A4 | 1.71e-04 | 395 | 72 | 8 | 752 |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 4.31e-04 | 8 | 72 | 2 | 658 | |
| GeneFamily | Zinc fingers CXXC-type | 1.01e-03 | 12 | 72 | 2 | 136 | |
| GeneFamily | PDZ domain containing | 3.17e-03 | 152 | 72 | 4 | 1220 | |
| Coexpression | GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN | 2.22e-06 | 196 | 113 | 8 | M8453 | |
| Coexpression | GSE27786_BCELL_VS_ERYTHROBLAST_DN | 2.64e-05 | 200 | 113 | 7 | M4811 | |
| Coexpression | GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN | 2.64e-05 | 200 | 113 | 7 | M7347 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-06 | 168 | 114 | 6 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 172 | 114 | 6 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 198 | 114 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.28e-05 | 200 | 114 | 6 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-05 | 161 | 114 | 5 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-05 | 162 | 114 | 5 | 0ccdb224ee3c585a6d0caffde5608d9d3cc452f8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-05 | 162 | 114 | 5 | 0d35752a7249b3c62b8007ec8a775c37d16b8d31 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-05 | 162 | 114 | 5 | 9ccee8e7e78e16b0149a94867e12d86d3b04f9b9 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-05 | 162 | 114 | 5 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.16e-05 | 83 | 114 | 4 | 1ab68323518adc7fd0a459b41fad12d60f97eb5c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.16e-05 | 83 | 114 | 4 | 75b27d91a4473286f4b40027e96ac5246f5abe5b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.64e-05 | 165 | 114 | 5 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.64e-05 | 165 | 114 | 5 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.43e-05 | 169 | 114 | 5 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 174 | 114 | 5 | 76310c0af1d7df6a4de3816838b2ac2892f68746 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.49e-05 | 178 | 114 | 5 | f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 9.49e-05 | 178 | 114 | 5 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.49e-05 | 178 | 114 | 5 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.75e-05 | 179 | 114 | 5 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-05 | 179 | 114 | 5 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-05 | 179 | 114 | 5 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-05 | 179 | 114 | 5 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 183 | 114 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 114 | 5 | 9e6c96ada930e8559246a270dfc69fb3cbb3bdf3 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 1.11e-04 | 184 | 114 | 5 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 185 | 114 | 5 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 185 | 114 | 5 | 01d0e848d8ede2745cfb10b070e2d9674ef4d477 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.17e-04 | 186 | 114 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-04 | 186 | 114 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.17e-04 | 186 | 114 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.17e-04 | 186 | 114 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.23e-04 | 188 | 114 | 5 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-04 | 191 | 114 | 5 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-04 | 193 | 114 | 5 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.39e-04 | 193 | 114 | 5 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 194 | 114 | 5 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 194 | 114 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.45e-04 | 195 | 114 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 195 | 114 | 5 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 197 | 114 | 5 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.53e-04 | 197 | 114 | 5 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.56e-04 | 198 | 114 | 5 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 198 | 114 | 5 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-04 | 198 | 114 | 5 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 198 | 114 | 5 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 198 | 114 | 5 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 198 | 114 | 5 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.60e-04 | 199 | 114 | 5 | 8649c2380285a668782d75eb076ce548eed0911d | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.64e-04 | 200 | 114 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-04 | 200 | 114 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.64e-04 | 200 | 114 | 5 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.64e-04 | 200 | 114 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-04 | 200 | 114 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.58e-06 | 182 | 113 | 8 | 1043_DN | |
| Disease | IGF-1 measurement | CARMIL1 GCKR SRCAP OGDH MED24 ASXL2 DDX60L HPS5 CRAMP1 DNMT1 MYBPC3 | 2.65e-06 | 488 | 112 | 11 | EFO_0004627 |
| Disease | oxoglutarate dehydrogenase deficiency (implicated_via_orthology) | 1.43e-05 | 2 | 112 | 2 | DOID:0081326 (implicated_via_orthology) | |
| Disease | signal peptide, CUB and EGF-like domain-containing protein 1 measurement | 8.53e-05 | 4 | 112 | 2 | EFO_0803074 | |
| Disease | neuropilin-1 measurement | 2.96e-04 | 7 | 112 | 2 | EFO_0020603 | |
| Disease | lysine measurement | 3.76e-04 | 37 | 112 | 3 | EFO_0005002 | |
| Disease | monocyte count | ASXL1 CARMIL1 GCKR OGDH LYST MED24 BAZ1A TKT PI4KA SSH2 DNMT1 RAPGEFL1 MYBPC1 MYBPC3 | 4.81e-04 | 1320 | 112 | 14 | EFO_0005091 |
| Disease | ornithine measurement | 6.29e-04 | 44 | 112 | 3 | EFO_0009776 | |
| Disease | phosphatidylcholine 34:1 measurement | 7.68e-04 | 11 | 112 | 2 | EFO_0010375 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 7.68e-04 | 11 | 112 | 2 | OBA_2045170 | |
| Disease | cortical thickness | NUP210L GATAD2B STAU1 NRP1 SCUBE1 DMRT3 KIAA0825 BAZ1A SH3PXD2A PI4KA IGSF9 SSH2 | 1.08e-03 | 1113 | 112 | 12 | EFO_0004840 |
| Disease | triacylglycerol 46:2 measurement | 1.26e-03 | 14 | 112 | 2 | EFO_0010402 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 1.45e-03 | 15 | 112 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | mean platelet volume | MPP3 SETD1B SLC35D2 NUP210L CARMIL1 GCKR SRCAP ZNF710 PI4KA ARHGEF3 MYBPC3 | 1.74e-03 | 1020 | 112 | 11 | EFO_0004584 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.98e-03 | 139 | 112 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | cognitive function measurement, self reported educational attainment | 2.39e-03 | 355 | 112 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | triacylglycerol 48:2 measurement | 3.14e-03 | 22 | 112 | 2 | EFO_0010405 | |
| Disease | mean corpuscular hemoglobin concentration | SETD1B SLC35D2 CARMIL1 MRPL30 ZDHHC5 GCKR LBR BAZ1A HECW2 RIC8A ASXL2 | 3.23e-03 | 1105 | 112 | 11 | EFO_0004528 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PIPVETLVKKKIPII | 526 | Q5FVE4 | |
| LIPPVKATPLKRFSQ | 51 | Q9NR81 | |
| NLKLPEPPRKVGIFL | 451 | O00478 | |
| EPSEPEIEIKLPKLR | 1126 | P26358 | |
| AKFPVTIRHPVIPKL | 296 | Q8NHY0 | |
| FPDRVLKIPRAVPVL | 166 | P51813 | |
| KGKFVLPLPICVIPE | 426 | Q9NU02 | |
| DPLPGRIKVDFVIPK | 281 | O75534 | |
| CFIPKRPIPTIKDVI | 911 | Q12882 | |
| PVDVKVKALPLPDRL | 391 | Q9NWX5 | |
| EPKVPPIRIQLSRIK | 566 | Q8IXJ9 | |
| IQVRKVPPLKIPVSR | 611 | Q76L83 | |
| DLKELPEPTPVKTRL | 406 | Q9NRL2 | |
| PLKPLKIRPVSQPFV | 446 | Q8N0U7 | |
| REVEVKLTPLILKPF | 111 | Q14739 | |
| RPIIKRFLGKLTIPV | 271 | Q9P2P5 | |
| ILPPILAETPKRAVK | 76 | Q9BQT8 | |
| FRKPIVPQKEPSPLL | 1291 | Q86U86 | |
| VIRRPPLTEKLLSKP | 16 | Q8TDR0 | |
| RSSKPIKRPVLDPFI | 421 | Q96AA8 | |
| EEKPLPIRPLKTTLR | 1166 | Q8IV33 | |
| KACRQPPIVFLPKLV | 1251 | Q4ZG55 | |
| KTEPPKIFRVKPVLG | 121 | Q8NI17 | |
| RLIPFVPKEKFIPKT | 596 | Q96JK4 | |
| PKLRLLEIKPEVELP | 91 | Q92784 | |
| LKFLPVPKAPEIDPV | 191 | Q9BXM9 | |
| KEKAIFPPRILSTRP | 4876 | Q2LD37 | |
| KKLLSLPPLPVITLR | 261 | Q9UPZ3 | |
| IPLPKIKRLLASSVP | 1326 | Q5H9U9 | |
| KKPAFLVPIVPLSFI | 76 | Q9HBL7 | |
| QILLPFRKPLIIFTP | 831 | Q9ULD0 | |
| LVTKKFPVDLRLPPV | 196 | Q92614 | |
| LKYRRETPLKPIPVE | 391 | O60437 | |
| LPPIKEAKPRLQKLF | 781 | P42356 | |
| PAKPVIPTAAKRIDL | 461 | P48167 | |
| LAAKKVPAPFKPVIR | 326 | O75582 | |
| LRKQLEKTLLEIPPP | 356 | Q8WXI9 | |
| FVKPATLRCVPKIRP | 151 | Q6ZSS7 | |
| EKSKPVPLKLFTPRL | 756 | P78316 | |
| VPLKLFTPRLVKVLE | 761 | P78316 | |
| YLKRLKIIIFPPIPD | 366 | P78552 | |
| PIPLKKLFPSIISIT | 446 | Q14397 | |
| PKPLITRFVRIKPAT | 396 | O14786 | |
| ILLPFRKPLIIFTPK | 846 | Q02218 | |
| CVPLPKIFIKRQAPL | 1391 | Q9Y2I7 | |
| KLEVIFAPKKRVPPF | 4486 | Q4G0P3 | |
| KLKFPTRPKVRVPTI | 521 | Q9Y2K7 | |
| PPIRKVAEIFVKAFP | 1356 | Q9H799 | |
| LAKLRKVPDVLPVLP | 496 | Q14241 | |
| LFIPPAKIIIPKFSL | 146 | A8MYV0 | |
| KANRPPLEVLKKIFP | 246 | Q9NQL9 | |
| KPVLSIDTEPRKPAL | 516 | Q96JM3 | |
| LPKEVRLSPKLILDP | 966 | Q5JV73 | |
| KELERPIKVPVVIPV | 401 | P82251 | |
| DQKPVRLPLKVPIEL | 311 | Q96RY5 | |
| LARYKLRIVKPPKLP | 21 | Q6PIV2 | |
| LTRLPSDKLKAVIPP | 546 | Q68DC2 | |
| LAPPILELREKLKPE | 516 | Q96BJ8 | |
| IPITLPIIASLRKEP | 96 | Q6P1S2 | |
| ILVIIVFKEKPKYPP | 266 | Q9UPI3 | |
| PVREITFPKSNKPII | 3741 | Q99698 | |
| SKFVRIAPVPIAAKP | 276 | Q9UIH9 | |
| LLPPVLKKVPSDKER | 1296 | Q5VZK9 | |
| TEFKRGLPLFPLVKP | 996 | P14735 | |
| VTTKVPFPLTLRFKP | 136 | Q9P0I2 | |
| RLFAKPPPVIKVESR | 421 | Q8IY37 | |
| PPKRRILIVVPEIFL | 831 | Q8IWY4 | |
| KALVKIVPVFLALIP | 316 | Q8N697 | |
| VFPPFRLLPEKMTLI | 1081 | Q5VU65 | |
| KGAPEKAIPLLPRLI | 146 | Q8N7B6 | |
| KAIPLLPRLIPVLKA | 151 | Q8N7B6 | |
| KKLLKTAFQPVPRRP | 471 | P78415 | |
| IFVKPAIQEKRKTPP | 501 | Q13368 | |
| EKPKLRFIERAPLVP | 46 | Q9NX20 | |
| KIHKEPYIRERPPLV | 5066 | O75445 | |
| PHIRPLEKEKVIPLV | 526 | O75691 | |
| KERITILLPKRPPKT | 126 | Q9BT43 | |
| FDKKIPVKLFPLPLL | 86 | Q76EJ3 | |
| SKPRNKRVPILPFVI | 311 | Q9UQF0 | |
| SKIVVPPLPGKALKR | 86 | Q9UMY4 | |
| LIRIKPLKLPQGLPA | 116 | Q8TCC3 | |
| ILPVILTFLPPSKKK | 841 | Q96NR3 | |
| FVLSPIKEPAKVSPR | 816 | Q8N3V7 | |
| LPPKRPIKEVLTDIF | 701 | O75448 | |
| DEKIKVRLPPPTILK | 576 | O14802 | |
| LPKVLPKLPKRVIVQ | 356 | Q6P3W7 | |
| AIRLPSFKVKRKEPP | 956 | Q9UPS6 | |
| KGPPRVLEPLKDVVL | 51 | A0A087WV53 | |
| RFKDKLPVPIPIEFI | 281 | P40879 | |
| SLVPPLETEKLPRKR | 3126 | Q6ZRS2 | |
| RPARKFLKAQVLPPL | 346 | Q9NPQ8 | |
| FIVAAVTKLPPIKVP | 591 | Q92935 | |
| VKKLSEQVFLPPRPP | 286 | Q96SZ6 | |
| IFPKVTCRPPKEVID | 2126 | Q63HN8 | |
| LINIIKPPVRDPKGF | 4601 | Q63HN8 | |
| KALELALKRPRPPVL | 266 | Q9ULJ3 | |
| VLFEIKKPPVSERLP | 101 | Q13432 | |
| REKIKVIKETPLPPS | 256 | O60858 | |
| VLDPFTIKPLDRKLI | 531 | P29401 | |
| LEELKKLPPLPAVER | 246 | O95793 | |
| VPLPLPKRVEIIEYT | 1001 | Q76I76 | |
| RFRHKIPVPIPIEVI | 291 | O43511 | |
| LIPPLPEKFVVKGVV | 151 | Q5VWJ9 | |
| DPKQRIIPFLPGKIL | 66 | Q5TCZ1 | |
| KLPKVPEAALPEVRL | 451 | Q9BXM0 | |
| LNSLDVKPLRKPRIP | 11 | Q9NRS4 | |
| PPVRLVPKVKFEKVE | 101 | Q8N1W2 | |
| IFPPELLRLKDTPRK | 211 | P47989 | |
| KVAPSILKPRKAPAL | 631 | Q9Y4R7 | |
| RVLLKAPPAFIERPK | 411 | Q9P2J2 | |
| PKRPRPLKLSVFFPI | 416 | Q92536 | |
| PKKEKTIVIRPPFLR | 256 | Q9C0B5 | |
| PIPLDRLVVKSIEPL | 606 | Q6ZR37 | |
| PVPFTKLPIVRHVKL | 531 | Q96Q05 | |
| PVIPFVPLILKDLTF | 571 | Q9UHV5 | |
| SLPPIFEILPVKSLK | 346 | Q6P2D8 | |
| QPILVKEIIEPPKIR | 826 | Q00872 | |
| ELFVKEPPVLITRPL | 446 | Q14896 |